Data as of Q4 2025 (Dec 31, 2025)

PERKINS CAPITAL MANAGEMENT INC

โ€ขCIK: 884300โ€ขFiling: Q4 2025

**PERKINS CAPITAL MANAGEMENT INC** A $126M-AUM manager maintaining a focused portfolio of 91 positions. The fund exhibits significant concentration in the biotech and technology sectors, highlighted by top holdings including NTRA ($10.2M) and LLY ($9.6M). Further notable allocations include AXGN ($7.5M) and IDXX ($6.6M), suggesting a deep conviction in innovative healthcare and semiconductor plays. This structure points to a high-conviction, sector-specific investment mandate.

Total AUM
$125.9M
QoQ Performance
+11.0%
Positions
91
Top 10 Concentration
46.7%
Latest Filing
Q4 2025

Top Holdings Allocation

NTRA
LLY
AXGN
IDXX
NTRA8.1%
LLY7.7%
AXGN5.9%
IDXX5.2%
MSFT4.7%
MDXHEALTH3.9%
AMD3.0%
ATEC2.9%

๐Ÿ“ˆ Biggest Buys

OWLT
OWLET INC
NEW
1.3% of portfolio
NEOG
NEOGEN CORP
NEW
1.0% of portfolio
PRN
PROFOUND MED CORP
NEW
0.7% of portfolio
VERI
VERITONE INC
NEW
0.6% of portfolio
TELA
TELA BIO INC
+67.6%
1.3% of portfolio

๐Ÿ“‰ Biggest Sells

BKSY
BLACKSKY TECHNOLOGY INC
-75.8%
0.4% of portfolio
CIEN
CIENA CORP
-33.0%
1.2% of portfolio
SKYT
SKYWATER TECHNOLOGY INC
-21.4%
1.9% of portfolio
HAIN
HAIN CELESTIAL GROUP INC
-60.9%
0.1% of portfolio
AXGN
AXOGEN INC
-3.3%
5.9% of portfolio

Sector Breakdown

Other75.3%
Healthcare13.7%
Technology9.5%
Energy0.6%
Communication0.4%
Financial0.4%
Consumer0.2%

๐Ÿšช Exited Positionssold since Q3 2025

DGX
QUEST DIAGNOSTICS INC
SOLD
$228.7K

Changes from Q3 2025

NEW9 new positions
โ†‘16 increased
โ†“49 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023